{"id":"W4376613897","doi":"10.1016/j.esmoop.2023.101392","title":"203P Clinical effectiveness of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer (mBC) by ER expression level: Subgroup analysis from phase IIIb LUCY trial","year":2023,"lang":"en","type":"article","venue":"ESMO Open","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia","funders":"Yonsei University College of Medicine; Merck Sharp and Dohme; Fundació Institut de Recerca Hospital Universitari Vall d’Hebron; Universitat de Barcelona; Medizinischen Hochschule Hannover; Hacettepe Üniversitesi; Gilead Sciences; Merck; AstraZeneca","keywords":"Medicine; Olaparib; Internal medicine; Oncology; Metastatic breast cancer; Taxane; Eribulin; Breast cancer; Population; Vinorelbine; Cancer; Chemotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001832152,0.0003596931,0.001820933,0.0003511031,0.00007614103,0.00004353768,0.0004932146,0.0001561306,0.001582452],"category_scores_gemma":[0.0003462522,0.0002953115,0.0003390954,0.002199582,0.0002496926,0.000446816,0.0003092313,0.0004574296,0.0000438105],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002813653,"about_ca_system_score_gemma":0.0003257047,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03620589,"about_ca_topic_score_gemma":0.002662118,"domain_scores_codex":[0.9958963,0.001266577,0.001019171,0.0008440471,0.0005295793,0.0004443162],"domain_scores_gemma":[0.9965979,0.001871342,0.000468984,0.0006306074,0.0002043203,0.0002268182],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.573763,0.008731153,0.2030048,0.0004560358,0.01493792,0.0006818562,0.004009252,0.002074354,0.04282731,0.0000413089,0.002948185,0.1465248],"study_design_scores_gemma":[0.2795612,0.001136457,0.6549069,0.001403861,0.002600189,0.000008785502,0.001009733,0.001092984,0.05570338,0.001023563,0.0009201686,0.0006327903],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991773,0.0001939738,0.002033961,0.0003931574,0.000379581,0.002488877,0.002565276,0.000065816,0.0001063567],"genre_scores_gemma":[0.9965014,0.0001256777,0.001018785,0.0001412924,0.0001538065,0.0006799026,0.0009191055,0.00006944981,0.0003905416],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.451902,"threshold_uncertainty_score":0.9999499,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09030039216248577,"score_gpt":0.4620253913515751,"score_spread":0.3717249991890894,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}